Concern Erupts Over WTO System And Medicines Shipments; TRIPS Talks Rekindling 03/02/2009 by William New, Intellectual Property Watch 8 Comments By William New The ambassadors to the World Trade Organization from Brazil and India on Tuesday charged that other WTO members had no grounds to block legitimate shipping of generic medicines on the basis of potential intellectual property rights conflicts in the transit country and said recent cases of doing so in the Netherlands call […]
IP Owners Face Tough Legal Issues In United States In 2009 30/01/2009 by William New, Intellectual Property Watch Leave a Comment By Steven Seidenberg for Intellectual Property Watch 2009 could be a bad year for IP owners in the United States. For patent owners, it may be particularly tough. The US courts are likely to continue their recent trend of cutting back on patent rights, according to many experts. The question is: what rights may be cut back and by how much? Copyright and trademark owners in the United States face a different set of troubles. They are struggling to protect their rights in the digital world, and it is far from certain how they will fare.
WIPO Ponders New Negotiating Style; DDG Positions Opening; Patent Filings Falter 29/01/2009 by William New, Intellectual Property Watch Leave a Comment By William New The World Intellectual Property Organization saw record patent filings again in 2008, but the rate of growth is slowing, WIPO Director General Francis Gurry said Tuesday. Meanwhile, the WIPO secretariat is privately exploring with member governments ways to break through a longstanding deadlock in policy negotiations underway at the UN institution, and […]
El esperado consenso en torno al informe y al proyecto de resolución sobre falsificación de la OMS se aplaza hasta la Asamblea de mayo 29/01/2009 by Catherine Saez, Intellectual Property Watch Leave a Comment Por Kaitlin Mara La semana pasada, un informe y un proyecto de resolución sobre la falsificación de productos médicos de la Organización Mundial de la Salud (OMS) generaron acalorados debates, aunque aún no se han logrado avenencias para salvar las distancias en lo relativo al proceso de consultas que subyace en dicho informe y el […]
OMS : l’espoir d’un consensus sur les contrefaçons reporté à l’Assemblée du mois de mai 29/01/2009 by Kaitlin Mara for Intellectual Property Watch Leave a Comment La semaine dernière, un rapport et un projet de résolution de l’Organisation mondiale de la santé (OMS) sur les produits médicaux contrefaits ont donné lieu à un débat animé, bien qu’aucun compromis n’ait encore été trouvé pour mettre fin aux désaccords quant au processus de consultation caché derrière le rapport sur les contrefaçons et au […]
Hope For Consensus On WHO And Counterfeits Moves To May Assembly 27/01/2009 by Kaitlin Mara for Intellectual Property Watch 1 Comment By Kaitlin Mara A World Health Organization report and draft resolution on counterfeit medical products drew energetic debate last week, though no compromise has yet been found to bridge disagreements over the consultation process behind the counterfeit report and over the risk of confusing intellectual property violations with potentially dangerous misrepresentation of medicines. Members agreed […]
Potential Names For Obama IP Team Swirl; WTO IP Chief “Imminent” 27/01/2009 by Liza Porteus Viana, Intellectual Property Watch 1 Comment By Liza Porteus Viana for Intellectual Property Watch and William New Changes in several key international agencies and governments will bring a cadre of new faces to positions that address intellectual property policy, and some potential names for those spots have been circulating in recent weeks. The naming of the new chief of the World Trade Organization IP Division is “imminent,” according to sources close to the process. And as US President Barack Obama began his first weeks in office in late January, many IP-related positions also remain unfilled.
New International Pharma Industry Leader Brings Prospect Of Change 23/01/2009 by William New, Intellectual Property Watch 1 Comment By William New Alicia Greenidge represents a change for the global pharmaceutical and biotechnology industry, but as she grows into her role as the head of the industry’s international trade association, it is unclear whether there will be substantive changes on policy relating to intellectual property and public health. Key policy areas include counterfeit medicines and funding for research and development into diseases afflicting poor populations in ways that echo past industry approaches, but Greenidge brings a new focus on networking and negotiation.
WHO Puts Nearly $150 Billion Price Tag On Global R&D Strategy For Neglected Diseases 22/01/2009 by Kaitlin Mara for Intellectual Property Watch 2 Comments By Kaitlin Mara Estimated funding needs for the implementation of the World Health Organization strategy on global public health and intellectual property have been revealed in a new document. The document lays out element by element the expected cost of implementing the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property […]
WHO Members Make Informal Progress On Plan Of Action As Executive Board Opens 20/01/2009 by Kaitlin Mara for Intellectual Property Watch Leave a Comment By Kaitlin Mara A small, diverse group of member states meeting informally over the weekend were able to resolve questions of which institutions should be actors in a broader plan of action for the implementation of the World Health Organization Global Strategy on Public Health, Innovation, and Intellectual Property, according to sources. The informal agreement […]